Rebetol and Marinol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rebetol and Marinol. Common interactions include depression among females and dental caries among males.

The phase IV clinical study analyzes what interactions people who take Rebetol and Marinol have. It is created by eHealthMe based on reports of 6 people who take Rebetol and Marinol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

6 people who take Rebetol and Marinol together, and have interactions are studied.


What is Rebetol?

Rebetol has active ingredients of ribavirin. eHealthMe is studying from 25,907 Rebetol users for its effectiveness, alternative drugs and more.

What is Marinol?

Marinol has active ingredients of dronabinol. It is often used in pain. eHealthMe is studying from 4,668 Marinol users for its effectiveness, alternative drugs and more.

Number of Rebetol and Marinol reports submitted per year:

Rebetol and Marinol drug interactions.

Common Rebetol and Marinol drug interactions by gender *:

female:

  1. Depression
  2. Medical device complication

male:

  1. Dental caries
  2. Depression
  3. Affect lability
  4. Aggression
  5. Anger
  6. Asthenia
  7. Blood pressure systolic increased
  8. Chest tightness
  9. Death
  10. Disturbance in attention

Common Rebetol and Marinol drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Blood pressure systolic increased
  2. Chest tightness
  3. Dyspnoea
  4. Fall
  5. Heart rate irregular
  6. Malaise
  7. Mitral valve incompetence
  8. Panic attack
  9. Supraventricular extrasystoles
  10. Tachycardia

30-39:

n/a

40-49:

  1. Suicidal ideation
  2. Tooth fracture
  3. Affect lability
  4. Aggression
  5. Anger
  6. Asthenia
  7. Disturbance in attention
  8. Impaired work ability
  9. Lethargy
  10. Tooth disorder

50-59:

  1. Confusional state
  2. Depression
  3. Medical device complication

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Rebetol and Marinol?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Rebetol and Marinol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Rebetol side effects:

Browse all side effects of Rebetol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Marinol side effects:

Browse all side effects of Marinol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Rebetol interactions:

Browse all interactions between Rebetol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Marinol interactions:

Browse all interactions between Marinol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ribavirin and dronabinol (the active ingredients of Rebetol and Marinol, respectively), and Rebetol and Marinol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Rebetol and Marinol.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: